Philogen Raises €62m To Advance Pipeline, Expand GMP Capacity

R&D
Philogen develops drugs for the treatment of angiogenesis-related disorders • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D